NADINE DAOU: Open Payments
NPI 1285180331 · NEWBURYPORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 17 payments from 11 companies in 2025. Trend: 2023 $514 · 2024 $701 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $108 |
| Novo Nordisk Inc | 2 | $57 |
| Boston Scientific Corporation | 1 | $54 |
| Amgen Inc. | 2 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Amneal Pharmaceuticals LLC | 1 | $28 |
| BETA BIONICS, INC. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
| Medtronic, Inc. | 1 | $19 |
Products named: JARDIANCE, Wegovy, General - Pain Management, EVENITY, UNITHROID, iLet Bionic Pancreas, GVOKE HYPOPEN, Repatha.
Industry payments across MA — which companies pay providers there.
